Matthew Byerly, M.D.
|Medical School||University of Arizona College of Med. (1990)|
The NIMH-CATIE Project: Schizophrenia Trial Design and Protocol Development
Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick I, Canive J, McGee M, Simpson G, Stevens M, Lieberman JA. Schiz Bull. In press
Industry Sponsored Research Involving Newer Antipsychotic Agents for the Treatment of Schizophrenia: Does Source of Funding Influence Design and Outcome?
Montgomery J, Byerly MJ, Carmody T, Li G, Varghese F, Holland R. Submitted to Schiz Bull
Cost Evaluation of Risperidone Versus Olanzapine: A Database and Chart Review Study
Byerly M, Weber M, Brooks D, Casey SB, Elliot S, Cross J, McConnell D, Hawkins J. Psychiatr Serv 2003 54/5 742-744
Antipsychotic Medications and the Elderly: Effects on Cognition and Implications for Use
Byerly MJ, Weber M, Snow L, Worley M, Lescouflair E. Drugs and Aging 2001 18 45-61